NCT01336933 2023-09-22
Combination Chemotherapy and Pralatrexate as First-Line Therapy in Treating Patients With Non-Hodgkin Lymphoma
University of Nebraska
Phase 2 Completed
University of Nebraska
Yale University
Alliance for Clinical Trials in Oncology
Translational Drug Development
University of California, Davis
British Columbia Cancer Agency